GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

GLP-1 RAs are very effective at lowering blood sugar levels. As an added bonus, some have also shown benefits for heart health and kidney function. However, some people may be better suited to ...

These drugs may also help preserve beta cell function ... role in the treatment of chronic kidney disease beyond glycemic control,” Azriel explained. GLP-1 analogs are being studied for their ...

GLP-1 agonists also were tied to 12% reduced risk for acute kidney injury and 3% lower risk ... and a stabilizing effect on endothelial function, which may be driving cardiovascular benefits ...

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

Patients using GLP-1 receptor agonists appear to have a lower risk of age-related macular degeneration and primary open-angle glaucoma. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs ...

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of worsening kidney disease in people with type 2 diabetes. The approval ...

New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial ... such as heart disease, kidney disease or vision loss, according to the Centers for Disease Control ...